RT @PennyBrohnUK: The role of the immune system in detecting and destroying cancer cells is now universally recognised as a key factor affe…
This T cell receptor appears to be able to target dozens of different cancer types while ignoring healthy tissues.. but what does it recognise!? https://t.co/T05OOucKh9
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
מאמר פסיכי
Will this be the end of cancer? https://t.co/q55DP1JQ2y
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @luigi_rav: « Human leukocyte antigen (HLA)-independent, T cell–mediated targeting of cancer cells would allow immune destruction of mal…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @PLMcCarthyMD: This is interesting. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC…
¡Brillante! Descritas células que se dirigen a una proteína ubicua llamada MR1 que reconoce los derivados de la vitamina B2. Esto Podría conducir a inmunoterapias generalizadas contra el cáncer y creació"vacunas contra el cáncer en todos los individuos.
RT @DrAnasYounes: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related prot…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
Mycket intressant läsning och något som verkligen borde fortsätta forskas ordentligt inom. https://t.co/MCRBFXThSR
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Promising findings in #immunotherapy that can lead to the cure of several different types of cancer. https://t.co/oaSPDstKbO
RT @GregoryGuilbert: @vbenard Les futures stratégies thérapeutiques de lutte contre le cancer seront à mon sens un mix entre chimiothérapie…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
The molecule MR1, a receptor with a structure close to MHC class I molecules, expressed by a wide range of cancer cells could serve as a target for certain T lymphocytes and could have great potential for cell therapy adoptive in cancer. https://t.co/7yYJQ
@vbenard Les futures stratégies thérapeutiques de lutte contre le cancer seront à mon sens un mix entre chimiothérapie ciblée (1 molécule pour 1 type de mutation) et thérapie cellulaire. Mais il y a encore du chemin à faire malgré de nombreuses avancées. E
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
COMMENTARY | One-Size-Fits-All Cancer Treatment? “A T-cell receptor recognized and killed most human cancer types via the monomorphic MHC class I-related protein.” #Health #Cancer Crowther, M.D. et al., In Press. Nature Immunology. https://t.co/tKSavzzT
What a good news! We’re starting on the IO era to treat cancer but I believe that is very exciting to achieve cure https://t.co/xYzPYuyqde
Major discovery! Ubiquitous cancer targeting Tcells! #crisprcas9 https://t.co/2SSi1VH9UF
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. https://t.co/ZRZmysPIL1 via @circleboom
For further information go to link: https://t.co/RR06exxvIT
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/nSHja8QbtV
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/3fJiDqkweu
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. https://t.co/317v7M9o2J https://t.co/AysLPo0coP
RT @gabyrabi: Un estudio revela la existencia de linfocitos T anti tumorales universales que eliminan varios tipos de tumores que expresan…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Scientists identify new type of immune cell with ability to attach to MR1 which might offer new way to tackle cancer #patientsfirst #endcancer https://t.co/Bdz1ymE5mH
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
The role of the immune system in detecting and destroying cancer cells is now universally recognised as a key factor affecting cancer outcomes. Many of the lifestyle approaches included in our Bristol Whole Life Approach have also been shown to improve imm
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Nat Immunol #metabolomics https://t.co/m8cEeRS6yk
#Speechless 🙏 #sciences #HealthTech #future #hope cc @dr_l_alexandre @Aurelie_JEAN
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @aliciads89: Fantastic work from our Cardiff colleagues and my former lab group!
RT @higeckil: Yeni! MR1: evrensel kanser aşısı yolda mı? Hemen hemen tüm kanserlerde hücre yuzeyinde ifade ediliyor. Ancak, normal hücreler…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @robertlufkinmd: Human leukocyte antigen independent, T cell–mediated targeting of cancer cells could allow immune destruction of malign…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
@pcgonenuts @MailOnline The #globalists are petrified of these being released, as it doesn't fit their #ClimateChange #HOAX agenda, but #PresidentTrump is forcing the information out... https://t.co/ShB2Dxqkzv & https://t.co/rxhFgnxb8v & https://t.
RT @robertlufkinmd: Human leukocyte antigen independent, T cell–mediated targeting of cancer cells could allow immune destruction of malign…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @Lo_Zanzi: Not all #MAIT cells are equal! @NatImmunol a new unconventional #TCR that recognizes #tumor #selfligands (possibly #cancer…
يوم امس اعلن باحثون في جامعة كارديف عن اكتشاف عظيم يمكن اعتباره حجر الاساس في رحلة علاج عديد الامراض السرطانية. خطوة عظيمة للانسانية https://t.co/JFo2X7J99t
RT @ReskiLab: @UniFreiburg A very short story about good and "not so good" science coverage in journalism. #scicomm #Wisskomm 1) Here is th…
Fantastic work from our Cardiff colleagues and my former lab group!
@UniFreiburg A very short story about good and "not so good" science coverage in journalism. #scicomm #Wisskomm 1) Here is the article from @nature Immunology: https://t.co/f5gPDBEu2y
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @Imwastntym: @ReflectingMan “The team says human trials on terminally ill patients could begin as early as November if the new treatment…
RT @DrAnasYounes: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related prot…
« Human leukocyte antigen (HLA)-independent, T cell–mediated targeting of cancer cells would allow immune destruction of malignancies in all individuals. Here, we use genome-wide CRISPR–Cas9 screening to establish that a T cell rec…https://t.co/5muCvb4hQA
RT @drug_smolecules: Initial thoughts on the new ubiquitous T cell cancer target published recently in @nature immunology https://t.co/xYcL…
RT @syinvesting: A new T cell receptor killed most human #cancer types via a single HLA-like molecule (MR1) in *mice*. MR1-restricted T-cel…
Yeni! MR1: evrensel kanser aşısı yolda mı? Hemen hemen tüm kanserlerde hücre yuzeyinde ifade ediliyor. Ancak, normal hücrelerde de var! Peki nasıl? Kanser hücreleri vitamin profili (özellikle B2 türevleri), belli T hücrelerinin sadece kanser MR1'larını🎯 h
Exciting opportunities for pan-cancer, pan-population T cell–mediated cancer immunotherapy approaches https://t.co/yu21mIFet1
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @goodlettlab1: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related prot…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @deepakmohoni: Link to study (2/2) : Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic M…
Link to study (2/2) : Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/BouGiindCT
Really exciting paper in Nature Immu on T-cell capability: ”TCR transfer to T cells of patients enabled killing of autologous and nonautologous melanoma. These findings offer opportunities for HLA-independent, pan-cancer, pan-population immunotherapies.”
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
Is MR1 the new magic universal target in cancer immünotherapy? We'll see it!
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @EricTopol: Discovery of a T cell receptor clone (via genome-wide #CRISPR) with the potential of pan-#cancer, pan-population immunothera…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
kind of really freaking out over this very cool application of CRISPR-Cas9 on cancer cells!!!!!! https://t.co/DmSarMyxNy
Several people have asked me about this study, sounds remarkable! We'll read it after my two grants are in! https://t.co/j5a79LQkfV
Genome-wide CRISPR–Cas9 screening reveals ubiquitous Tcell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/wpW5MLXIJk
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…
RT @davidasinclair: Wow! Immune cells found to target a cancer-ubiquitous protein called MR1 that recognizes vitamin B2 derivatives. Could…